Skip to main content
3SBio Inc. logo

3SBio Inc. — Investor Relations & Filings

Ticker · 1530 ISIN · KYG8875G1029 LEI · 529900P0TQC1E9Y7FN31 HKEX Manufacturing
Open in API
Filings indexed 1,492 across all filing types
Latest filing 2017-03-17 Annual Report
Country KY Cayman Islands
Listing HKEX 1530

About 3SBio Inc.

http://www.3sbio.com

3SBio Inc. is a biopharmaceutical enterprise specializing in the integrated research, development, production, and commercialization of innovative biopharmaceutical products. The company operates as a biotechnology firm, focusing on the discovery, development, manufacture, and marketing of biologics, with a particular emphasis on mammalian cell-based biopharmaceuticals. 3SBio addresses critical medical needs by providing an extensive range of products and services to markets both domestically and internationally.

Recent filings

Filing Released Lang Actions
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2016
Annual Report Classification · 100% confidence The document is titled 'ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2016' and contains detailed consolidated financial statements including profit or loss, comprehensive income, financial position, and notes on accounting policies and segment information. It includes extensive financial data and analysis for the full fiscal year ending December 31, 2016. The length of the document is about 15,000 characters, indicating it is a full report rather than a brief announcement. The content matches the characteristics of an official yearly report covering company activity and full financial performance, which corresponds to an Annual Report (10-K equivalent) filing. There is no indication that this is merely an announcement of a report or a certification letter, so it is not RPA or RNS. Therefore, the appropriate classification is Annual Report (10-K). FY 2016
2017-03-17 English
NOTICE OF BOARD MEETING
Regulatory Filings Classification · 95% confidence The document is a short announcement from 3SBio Inc. regarding a scheduled board meeting to consider and approve the annual results for the year ended 31 December 2016 and the payment of a final dividend. It does not contain any financial data or the actual annual report but merely notifies the market of the upcoming board meeting. The length is only 1342 characters, which is quite short and fits the pattern of an announcement rather than a full report. According to the rules, such announcements about meetings to approve results are classified as Regulatory Filings (RNS) because they do not contain the report itself but are regulatory announcements related to corporate governance and reporting schedules.
2017-03-07 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2017
Capital/Financing Update Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' and is addressed to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized and issued share capital, share options, warrants, convertibles, and other share-related transactions for the month ended 28/02/2017. The content focuses on changes in share capital and securities, including share options and warrants, rather than financial performance, earnings, or management commentary. This type of document is typically a regulatory filing reporting capital changes and share movements to the exchange. It is not an annual or interim report, earnings release, or management discussion. Given the detailed share capital movements and the regulatory context, the most appropriate classification is 'Capital/Financing Update' (CAP). The document length and detail confirm it is not a brief announcement or a report publication notice, but a substantive update on capital movements.
2017-03-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2017
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 28/02/2017. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions. The content focuses on share capital changes and movements in securities rather than financial performance, earnings, or management commentary. It is a regulatory disclosure related to share capital movements submitted to the Hong Kong Exchanges and Clearing Limited. This type of document fits best under 'Share Issue/Capital Change' (SHA) as it reports on changes in share capital and related securities.
2017-03-01 English
BUSINESS UPDATE
Regulatory Filings Classification · 95% confidence The document is an announcement from 3SBio Inc. regarding the inclusion of three of its products in the 2017 National Reimbursement Drug List published by the Ministry of Human Resources and Social Security of China. It provides a business update on product listings and market implications but does not contain financial statements, earnings data, or detailed financial analysis. The document is not a full financial report, earnings release, or regulatory filing of financial results. It is a business update announcement related to product reimbursement status and market positioning. Therefore, it fits best under the category of a general regulatory announcement or business update, which aligns with Regulatory Filings (RNS). The document length is about 5,130 characters, which is sufficient for a substantive announcement but does not constitute a full report like an Annual or Interim Report.
2017-02-23 English
INSIDE INFORMATION ANNOUNCEMENT - PROFIT WARNING
Regulatory Filings Classification · 95% confidence The document is an announcement titled 'INSIDE INFORMATION ANNOUNCEMENT' and 'PROFIT WARNING' issued by Hongkong Chinese Limited. It references a preliminary assessment of financial results for the year ending 31 March 2017, based on unaudited information and not reviewed by auditors. The document is relatively short (3954 characters) and serves to inform shareholders and investors about expected financial performance and caution in dealing with shares. It does not contain detailed financial statements or comprehensive financial analysis. It is a regulatory announcement providing a profit warning rather than a full financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2017-02-17 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.